News

SEC Filings

Document Details

Form
Filing Date
November 8, 2023
Document Date
November 3, 2023
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Viret Jean-Frederic

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com